Study finds rapid genome sequencing boosts pediatric diagnoses at Seattle Children's
Go back to Study finds rapid genome sequencing boosts pediatric diagnoses at Seattle Children's| (NASDAQ: WGS) | Delayed: 88.40 -0.08 (0.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $88.48 | 52 Week High | $ | |||
| Open | $89.00 | 52 Week Low | $ | |||
| Day High | $90.99 | P/E | N/A | |||
| Day Low | $86.14 | EPS | $ | |||
| Volume | 510,361 | |||||
